^
    Back
    Association details:
    Biomarker:INPP4B overexpression
    Cancer:Acute Myelogenous Leukemia
    Drug:doxorubicin hydrochloride (Topoisomerase II inhibitor)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: C3 – Early Trials
    New
    Source:
    Royal Society of Chemistry
    Title:

    LncRNA ZEB2-AS1 regulates the drug resistance of acute myeloid leukemia via the miR-142-3p/INPP4B axis

    Excerpt:
    The mRNA expression of INPP4B was up-regulated in the BM tissues from AML patients and chemo-resistant AML patients compared with that from normal patients and chemo-sensitive AML patients...
    DOI:
    10.1039/C9RA07854A